Лучшие больницы для «Breast Augmentation» в Дубай, ОАЭ

Breast augmentation (augmentation mammaplasty) is one of the most performed elective plastic surgery procedures globally, with over 1.8 million procedures carried out worldwide annually according to ISAPS data. The surgery addresses hypomastia (insufficient breast volume), post-lactational involution, developmental asymmetry, and Poland syndrome-related chest wall deformity. Beyond aesthetics, the physiological impact extends to postural balance—significant volume discrepancies can cause compensatory cervical and thoracic strain—and to psychological well-being, where validated tools such as the BREAST-Q patient-reported outcome measure consistently demonstrate improvements in self-image, sexual well-being, and psychosocial function following successful augmentation.

• Women aged 18 years or older (minimum 22 years for silicone gel implants per FDA labelling, though international guidelines may differ slightly)
• Patients with hypomastia, breast asymmetry of ≥1 cup-size differential, post-partum breast volume loss, or congenital chest wall deformities such as Poland syndrome or tuberous breast deformity
• Patients with a stable body weight (BMI ideally 18.5–30 kg/m²) for at least 6 months prior to surgery
• Non-smokers, or patients who have ceased smoking for a minimum of 6 weeks pre-operatively (nicotine impairs wound healing and increases capsular contracture risk)
• Patients with adequate soft tissue coverage: a pinch test of ≥2 cm is preferred for subglandular placement; ≤2 cm typically indicates the dual-plane or submuscular approach
• +1 more

Required Diagnostics:

• Bilateral breast ultrasound (standard); MRI for patients over 40, those with dense tissue (BIRADS C or D), or personal/family history of breast disease
• Baseline mammography in patients ≥40 years or as clinically indicated
• 3D volumetric imaging (Vectra XT / Crisalix simulation) for implant size and profile planning
• Routine pre-operative bloods: CBC, coagulation profile (PT/INR/aPTT), metabolic panel, HbA1c if diabetic
• ECG and anaesthetic fitness assessment for patients over 45 or with cardiopulmonary comorbidities
• +1 more

Breast augmentation encompasses several distinct surgical strategies, each selected based on patient anatomy, tissue characteristics, implant type, and aesthetic goals.

Implant-based Augmentation (primary TECHNIQUE):

1. Incision Approaches:

• Inframammary fold (IMF) incision: The most commonly used approach globally; provides direct, precise pocket dissection and is preferred for anatomical/shaped implants. Scar is concealed within the natural breast fold.
• Periareolar incision: Semi-circular incision along the inferior areolar border; suitable for simultaneous mastopexy or correction of tuberous breast. Carries slightly higher risk of sensory nerve disruption and biofilm contamination.
• Transaxillary incision: Scar placed in the axillary crease; no breast scar. Performed endoscopically using a lighted retractor system. Technically demanding; limited pocket control for large implants.
• Transumbilical breast augmentation (TUBA): Used exclusively with saline implants; rarely performed in modern practice due to limited implant selection and pocket control.

PHASE 1 — PRE-OPERATIVE PLANNING (4–8 weeks before travel):

• GAF Healthcare assigns a dedicated Patient Coordinator who collects medical history, current medications, and previous imaging reports.
• Virtual consultation with the operating plastic surgeon (video call) for anatomical assessment, goal alignment, and implant simulation using digital imaging.
• Pre-operative investigations (bloods, ECG, breast ultrasound/MRI) arranged either at the patient's home country or upon arrival; reports reviewed by the surgical team.
• e-Medical visa application assistance initiated for India-bound patients (typically approved within 3–5 business days); UAE entry visa or visa-on-arrival guidance provided for UAE-bound patients.
• Anaesthetic fitness questionnaire completed; any concurrent medications reviewed (aspirin, NSAIDs, oral contraceptives, anticoagulants adjusted per protocol).

PHASE 2 — ARRIVAL & IMMEDIATE PRE-OPERATIVE (Day 0–1):